logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SWIRE PACIFIC B(00087) spent 1.704 million Hong Kong dollars on November 14 to repurchase 165,000 shares.

date
18:43 14/11/2024
avatar
GMT Eight
The announcement made by Swire Pacific Limited B (00087) reveals that they spent 1.704 million Hong Kong dollars on November 14, 2024...
SWIRE PACIFIC B (00087) announced that on November 14, 2024, they spent 1.704 million Hong Kong dollars to repurchase 165,000 shares, at a repurchase price of 10.28-10.46 Hong Kong dollars per share.
Related Articles
HK Stock
YIDU TECH (02158) wins a bid for a 7.39 million yuan AI medical order. Recently, it has been awarded multiple top medical institution projects.
HK Stock
ZXZN QI-HOUSE (08395) suspended trading briefly in the afternoon of May 21st.
HK Stock
GRAND PHARMA (00512) nuclear medicine partner Telix innovative product TLX101 for the treatment of newly diagnosed primary glioblastoma overseas phase I study made a key progress setting a new benchmark for global brain cancer treatment.
YIDU TECH (02158) wins a bid for a 7.39 million yuan AI medical order. Recently, it has been awarded multiple top medical institution projects.
HK Stock
ZXZN QI-HOUSE (08395) suspended trading briefly in the afternoon of May 21st.
HK Stock
GRAND PHARMA (00512) nuclear medicine partner Telix innovative product TLX101 for the treatment of newly diagnosed primary glioblastoma overseas phase I study made a key progress setting a new benchmark for global brain cancer treatment.
HK Stock
RECOMMEND
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
icon
21/05/2026
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
icon
21/05/2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
icon
21/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.